by Combat Cancer | Jul 7, 2023 | News
We are excited to announce the proposed BCG-Unresponsive Trial – Combat HIVEC HEAT – in partnership with Leicester University Clinical Trials Unit. This is a phase 3, multi-centre, single-arm interventional trial of HIVEC® with Medac mitomycin C + maintenance for...
by Combat Cancer | Dec 1, 2022 | News
Press release, 1 December 2022 Combat Medical is pleased to announce the results of the HIVEC I phase 3 randomised controlled trial, published in European Urology Oncology on 23 November 2022. As with this year’s HIVEC II publication, this short-term regimen shows...
by Combat Cancer | Aug 22, 2022 | News
Press release, 22 August 2022 Combat Medical is pleased to announce the results of the HIVEC® II trial, published in European Urology on 20 August 20221. It is one in a series of recent HIVEC® publications helping chemo-hyperthermia to find its place in the treatment...
by Combat Cancer | Apr 12, 2022 | News
Once upon a time, some sharp-thinking medic came up with a great idea for neatly removing unwanted bits of tissue from their patient – the scalpel. But using it could be a bloody, messy process. Then another bright spark had an even better idea. What about...
by Combat Cancer | Apr 12, 2022 | News
Almost £40 billion of R&D funding was announced for the UK in the Chancellor’s Spring Statement. It follows on from his Autumn 2021 Budget and Spending Review, which included a boost for public R&D funding, taking it to £20 billion by 2024-25. This is an...
by Combat Cancer | Apr 5, 2022 | News
When you’re developing new medical devices, it’s not good enough simply to have a great product. The challenges for small companies and start-ups in this highly competitive environment are many. By Edward Bruce-White Combat Medical’s patented technology is...
Recent Comments